
Lorniross P 8mg/325mg Tablet
Marketer
Rosswelt Biosciences
Salt Composition
Lornoxicam (8mg) + Paracetamol (325mg)
Overview Lorniross P 8mg/325mg Tablet
Loripac 8mg/325mg tablets provide pain relief. This medication addresses pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. It also offers relief from muscle aches, back pain, dental pain, and ear/throat discomfort. For optimal absorption, Loripac 8mg/325mg tablets should be taken on an empty stomach. Dosage is determined by the specific condition and symptom response, always following your physician's instructions. Never exceed the prescribed dosage or duration. Commonly reported side effects include nausea, vomiting, dyspepsia, abdominal pain, and diarrhea. Report any persistent or worsening side effects to your doctor, who can offer strategies for mitigation. Prior to commencing treatment, inform your doctor of any pre-existing stomach ulcers or bleeding, hypertension, or cardiovascular, renal, or hepatic issues. Complete disclosure of all other medications is crucial, as interactions may occur. Consult your doctor before using this medication during pregnancy or breastfeeding. Alcohol consumption should be avoided due to the risk of increased drowsiness.
Primary Ingredients of Lorniross P 8mg/325mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Lorniross P 8mg/325mg Tablet
Analgesia
Major Benefits of Lorniross P 8mg/325mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Lorniross P 8mg/325mg Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Lorniross P 8mg/325mg Tablet:
- Nausea
- Vomiting
- Indigestion
- Stomach pain
- Diarrhea
How to use Lorniross P 8mg/325mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Lorniross P 8mg/325mg tablets on an empty stomach.
How Lorniross P 8mg/325mg Tablet works:
Each Lorniross P 8mg/325mg tablet combines lornoxicam and paracetamol to alleviate pain. This dual action inhibits the production of substances responsible for pain signaling and inflammatory responses like swelling and redness.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Lorniross P 8mg/325mg tablets.
PregnancyCONSULT YOUR DOCTOR
Pregnancy data on the use of Lorniross P 8mg/325mg tablets are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Lorniross P 8mg/325mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Lorniross P 8mg/325mg Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The combination medication Lorniross P 8mg/325mg tablets may be administered to patients with renal impairment without necessitating dosage modification.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Lorniross P 8mg/325mg tablets to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Lorniross P 8mg/325mg Tablet :
Should you forget a Lorniross P 8mg/325mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lorniross P 8mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
